Roble Belko & Company’s Labcorp LH Stock Holding History

Roble Belko & Company’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-102	Closed	-$13K	–	353
2019 Q1	$13K	Hold	102	–	–	﹤0.01%	203
2018 Q4	$11K	Hold	102	–	–	﹤0.01%	197
2018 Q3	$15K	Hold	102	–	–	0.01%	185
2018 Q2	$16K	Hold	102	–	–	0.01%	182
2018 Q1	$14K	Buy	+102	New	+$15K	0.01%	200
2017 Q2	–	Sell	-10	Closed	-$1K	–	326
2017 Q1	$1K	Hold	10	–	–	﹤0.01%	325
2016 Q4	$1K	Sell	10 -1,038	-99%	-$115K	﹤0.01%	342
2016 Q3	$124K	Hold	1,048	–	–	0.07%	66
2016 Q2	$117K	Buy	+1,048	New	+$113K	0.06%	67

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Roble Belko & Company's LH Position: Q2 2019 in Review

Roble Belko & Company sold out of Labcorp (LH) in Q2 2019, closing a stake of 102 shares — an estimated $13K sold.

Roble Belko & Company first reported a position in LH in Q2 2016 and held it in 9 quarters. The position peaked at $124K in Q3 2016. 741 funds tracked by Wall St. Rank hold LH as of Q2 2019.

Roble Belko & Company reported no remaining Labcorp position as of Q2 2019 after selling out during the quarter.
Roble Belko & Company sold 102 Labcorp shares in Q2 2019, an estimated $13K.
Roble Belko & Company first reported a position in Labcorp in Q2 2016 and held it in 9 quarters.
Roble Belko & Company's Labcorp position peaked at $124K in Q3 2016.
741 funds tracked by Wall St. Rank held Labcorp as of Q2 2019.

Based on Roble Belko & Company's 13F filing for Q2 2019, filed 13 Aug 2019.